Fundraising Fox

PDX Pharmaceuticals

Portland, US · Oregon corporation

PDX Pharmaceuticals develops mesoporous silica nanoparticle platforms to co-deliver drugs, siRNA, and immunotherapy for treating multiple cancers and skin diseases. The company works in collaboration with OHSU on targeted and combination immunotherapeutics.

Founders & leadership

WY
Wassana YantaseeinFounder & CEO
WN
Worapol NgamcherdtrakulinCo-founder · Head of Research & COO
AH
Angela HultNamed on SEC filing
JG
Joe GrayNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 1 round · 2019

$1.6MraisedNov 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wassana YantaseeExecutive Officer, Director
  • Angela HultDirector
  • Joe GrayDirector
  • Worapol NgamcherdtrakulExecutive Officer
Offering amount
$4M
Amount sold
$1.6M
First sale
Nov 2019
Incorporated
Corporation, Oregon
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with PDX Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does PDX Pharmaceuticals do?
PDX Pharmaceuticals develops mesoporous silica nanoparticle platforms to co-deliver drugs, siRNA, and immunotherapy for treating multiple cancers and skin diseases. The company works in collaboration with OHSU on targeted and combination immunotherapeutics.
Who founded PDX Pharmaceuticals?
PDX Pharmaceuticals was founded by Wassana Yantasee, Worapol Ngamcherdtrakul.
How much funding has PDX Pharmaceuticals raised?
PDX Pharmaceuticals has disclosed $1.6M raised across 1 round.
Where is PDX Pharmaceuticals headquartered?
PDX Pharmaceuticals is headquartered in Portland, US.